公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
公司地址 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
電話號碼 +1 415 851-0195
傳真號碼 --
公司網頁 https://www.forhims.com
員工數量 2442
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Andrew Dudum Chief Executive Officer and Chairman of the Board 美元 494.79K 28/04/2026
Dr. Patrick H. Carroll, M.D. Director and Global Chief Medical Officer -- 28/04/2026
Ms. Soleil Boughton Chief Legal Officer and Corporate Secretary 美元 464.38K 28/04/2026
Ms. Irene Becklund Senior Vice President, Controller and Chief Accounting Officer -- 28/04/2026
Ms. Deborah M. Autor Chief Policy Officer and Director -- 28/04/2026
Mr. Mohamed Elshenawy Chief Technology Officer 美元 375.00K 28/04/2026
Mr. Oluyemi Okupe Chief Financial Officer 美元 530.88K 28/04/2026
Mr. Michael Chi Chief Operating Officer 美元 485.00K 28/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Kare Schultz Independent Director 28/04/2026
Mr. Kofi Amoo-Gottfried Independent Director 28/04/2026
Mr. Christopher D. Payne Independent Director 28/04/2026
Mr. David Bolling Wells Lead Independent Director 28/04/2026
Ms. Christiane Pendarvis Independent Director 28/04/2026
Ms. Anja L. Manuel Independent Director 28/04/2026
Mr. Andrew Dudum Chief Executive Officer and Chairman of the Board 28/04/2026
Dr. Patrick H. Carroll, M.D. Director and Global Chief Medical Officer 28/04/2026
Dr. Delos M. Cosgrove, M.D. Independent Director 28/04/2026
Ms. Andrea G. Perez Garcia Independent Director 28/04/2026
Ms. Deborah M. Autor Chief Policy Officer and Director 28/04/2026
 
所屬ETF (更新日期: 02/05/2026 02:25)
代號 名稱 佔比% 持有日期
AVUQAvantis U.S. Quality ETF0.0002%29/04/2026
ANEWProShares MSCI Trnsfmtnl Chngs ETF0.0002%29/04/2026
RILAIndexperts Gorilla Aggressive Growth ETF0.0002%29/04/2026
QMIDWisdomTree U.S. Mid Cap Quality Gr0.0002%28/04/2026
SCDSJPMorgan Fundamental Data Sci Sm Cor ETF0.0002%29/04/2026
RESMColumbia Research Enhanced Small Cap ETF0.0001%29/04/2026
HDGProShares Hedge Replication0.0001%29/04/2026
AVTMAvantis Total Equity Markets ETF0.0001%29/04/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%29/04/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%29/04/2026
AVSUAvantis Responsible US Equity ETF0.00001%29/04/2026
AAEQAlpha Architect US Equity 2 ETF<0.000001%30/03/2026
AAUSAlpha Architect US Equity ETF<0.000001%08/08/2025
AFMCFirst Trust Active Factor Mid Cap ETF<0.000001%10/12/2025
AFSMFirst Trust Active Factor Small Cap ETF<0.000001%24/02/2026
AQECAQE Core ETF<0.000001%28/11/2025
AVLCAvantis U.S. Large Cap Equity ETF<0.000001%31/01/2026
AVMCAvantis U.S. Mid Cap Equity ETF<0.000001%10/02/2026
BFORBarron's 400 ETF<0.000001%19/09/2025
BOUTCapForce IBD® Breakout Opportunities ETF<0.000001%22/10/2025
  1    2    3    4   5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.